After the London Whale trading fiasco, many investors have sworn off allocating any of their funds to JPMorgan Chase (NYSE:JPM) and often point to lack of trust as their reason.

Motley Fool writers Ilan Moscovitz and John Reeves recently laid out why they wouldn't touch JPMorgan's stock

However, in classic Fool fashion, health-care analyst Max Macaluso sought to hear the other side of the story and sat down with banking analyst David Hanson. In this video, David acknowledges the hesitation to trust the JPMorgan management team but highlights the enormously profitable enterprise and its bright future.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.